3-(1,3-dioxolan-2-yl)phenol
|
克立硼羅雜質(zhì)71
|
7070-85-1
|
1,3-Dichloro-2-Methylpropane
|
1,3-DICHLORO-2-METHYLPROPANE
|
616-19-3
|
1-Phenylpropane-1,2-Diol
|
PHENYLPROPANEDIOL
|
1855-09-0
|
Sulfamic Acid Methyl Ester
|
氨基磺酸甲酯
|
55665-95-7
|
1,2-bis(4,5-dihydrothiazol-2-yl)disulfane
|
2,2'-二硫基雙-2-噻唑啉
|
2801-13-0
|
3-hydroxypiperidine-2-carboxylic acid
|
|
56879-47-1
|
TD-106(3-(5-amino-4-oxobenzo[d][1,2,3]triazin-3(4H)-yl)piperidine-2,6-dione)
|
TD-106
|
2250288-69-6
|
Thalidomide-NH-CH2-COO(t-Bu)
|
沙利度胺-NH-C2-NH-COO(T-BU)
|
2093386-23-1
|
Thalidomide-NH-(CH2)2-NH-Boc
|
沙利度胺-NH-C2-NH-Boc
|
1957235-57-2
|
Thalidomide-NH-(CH2)3-NH-Boc
|
沙利度胺-NH-C3-NH-BOC
|
2093386-36-6
|
Thalidomide-5-O-CH2-COO(t-Bu)
|
ACETIC ACID, 2-[[2-(2,6-DIOXO-3-PIPERIDINYL)-2,3-DIHYDRO-1,3-DIOXO-1H-ISOINDOL-5-YL]OXY]-, 1,1-DIME
|
2682112-10-1
|
Thalidomide-5-O-CH2-COOH
|
2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代異吲哚-5-基)氧基)乙酸
|
2467425-53-0
|
Thalidomide-4-propargyl
|
2-(2,6-dioxopiperidin-3-yl)-4-(prop-2-yn-1-yloxy)isoindoline-1,3-dione
|
2098487-39-7
|
Thalidomide-4-NH-PEG1-NH-Boc
|
沙利度胺-NH-PEG1-NH-BOC
|
2154342-17-1
|
Thalidomide-4-NH-PEG2-COO(t-Bu)
|
PROPANOIC ACID, 3-[2-[2-[[2-(2,6-DIOXO-3-PIPERIDINYL)-2,3-DIHYDRO-1,3-DIOXO-1H-ISOINDOL-4-YL]AMINO]E
|
2140807-16-3
|
VH032-NH-CO-CH2-Br
|
|
2379404-33-6
|
INDEX NAME NOT YET ASSIGNED
|
標準品RN1331
|
2111829-84-4
|
L-Prolinamide, N-[(1,1-dimethylethoxy)carbonyl]-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (4R)-
|
標準品RN1332
|
1448189-66-9
|
L-Prolinamide, N-[4-[[(1,1-dimethylethoxy)carbonyl]amino]-1-oxobutyl]-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (4R)-
|
標準品RN1333
|
2361119-87-9
|
L-Prolinamide, N-[6-[[(1,1-dimethylethoxy)carbonyl]amino]-1-oxohexyl]-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (4R)-
|
標準品RN1334
|
2412055-00-4
|
L-Prolinamide, N-[8-[[(1,1-dimethylethoxy)carbonyl]amino]-1-oxooctyl]-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (4R)-
|
標準品RN1335
|
2306389-02-4
|
L-Prolinamide, N-[2-[2-[[(1,1-dimethylethoxy)carbonyl]amino]ethoxy]acetyl]-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (4R)-
|
標準品RN1336
|
2409007-41-4
|
L-Prolinamide, N-(12,12-dimethyl-1,10-dioxo-3,6,11-trioxa-9-azatridec-1-yl)-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (4R)-
|
標準品RN1337
|
2162120-75-2
|
INDEX NAME NOT YET ASSIGNED
|
標準品RN1338
|
2827750-24-1
|
INDEX NAME NOT YET ASSIGNED
|
標準品RN1339
|
2827750-25-2
|
(Z)-Methyl 3-Aminobut-2-Enoate
|
Β-氨基巴豆酸甲酯
|
21731-17-9
|
Ethyl (Z)-3-Aminobut-2-Enoate
|
3-氨基巴豆酸乙酯
|
626-34-6
|
Ethyl (E)-3-Ethoxybut-2-Enoate
|
3-乙氧基-2-丁烯酸乙酯
|
57592-45-7
|
1-(pyridin-4-yl)urea
|
(吡啶-4-基)脲
|
13262-38-9
|
1,3-di(pyridin-4-yl)urea
|
N,N'-DI-4-PYRIDINYLUREA
|
39642-87-0
|
picolinoyl chloride
|
2-吡啶甲酰氯
|
29745-44-6
|
3-oxobutanal
|
乙酰乙醛
|
625-34-3
|
Aprepitant Impurity 2
|
阿瑞匹坦中間體
|
171482-05-6
|
Betahistine Impurity 4
|
2-(羥甲基)-2-(吡啶-2-基)丙烷-1,3-二醇
|
37445-98-0
|
Cefditoren sodium
|
頭孢妥侖鈉
|
104146-53-4
|
Chlorphenamine EP Impurity C
|
N-desmethylchlorpheniramine
|
20619-12-9
|
Dexrazoxane impurity 8
|
右雷佐生雜質(zhì)5
|
2084092-84-0
|
Dexrazoxane impurity 12
|
右丙亞胺雜質(zhì)3
|
120418-76-0
|
Edoxaban impurity 13
|
依度沙班雜質(zhì)C(鹽酸鹽)
|
1243308-37-3
|
Fosaprepitant impurity 3
|
阿瑞吡坦磷的二卞酯
|
265121-01-5
|
Fosaprepitant impurity 4
|
福沙匹坦-SSR對映異構(gòu)體
|
1523569-86-9
|
Fosaprepitant impurity 5
|
Fosaprepitant diMegluMine Impurity 2
|
1185503-00-7
|
Fosaprepitant impurity 7
|
Fosaprepitant Impurity 1
|
172822-01-4
|
Fosaprepitant impurity 8
|
Fosaprepitant diMegluMine Impurity 4
|
1523569-89-2
|
Fusidic Acid EP Impurity J( Sodium Fusidate EP Impurity J)
|
夫西地酸(褐霉酸)雜質(zhì)J(EP)
|
13011-12-6
|
Gadobutrol Impurity 7
|
釓布醇雜質(zhì)72
|
54364-78-2
|
Gemcitabine EP Impurity B
|
吉西他濱雜質(zhì)B
|
95058-85-8
|
Gemcitabine EP Impurity B HCl
|
1'-吉西他濱異構(gòu)體鹽酸鹽
|
122111-05-1
|
Gemcitabine impurity 4
|
吉西他濱雜質(zhì)31
|
866473-31-6
|
Gemcitabine impurity 5
|
吉西他濱雜質(zhì)32
|
1258595-49-1
|
Gemcitabine impurity 6
|
2,2-二氟-1-甲磺酰氧基-2-脫氧核糖-3,5-二苯甲酸酯
|
134877-43-3
|
Gemcitabine impurity 8
|
吉西他濱雜質(zhì)9
|
2174019-90-8
|
Gemcitabine impurity 9
|
2-脫氧-2,2-二氟-D-赤式戊呋喃酮糖-3,5-二苯甲酸酯
|
122111-02-8
|
Gemcitabine impurity 10
|
3-(2,2-二甲基-1,3-二氧戊環(huán)-4-基)-2,2-二氟-3-羥基丙酸乙酯
|
928797-50-6
|
Atorvastatin EP Impurity K
|
阿托伐他汀甲酯
|
345891-62-5
|
Avatrombopag impurity 45
|
阿伐曲泊帕雜質(zhì)408
|
832088-14-9
|
Vancomycin Impurity 1
|
56-亞硝基-萬古霉素
|
155386-25-7
|
Vancomycin EP Impurity D
|
萬古霉素雜質(zhì)
|
101485-50-1
|
Vancomycin EP Impurity A
|
萬古霉素雜質(zhì)
|
91700-98-0
|
Terbutaline EP Impurity D
|
特布他林EP雜質(zhì)D
|
94109-61-2
|
Trifluridine Impurity 4
|
曲氟尿苷雜質(zhì)14
|
362607-81-6
|
Terazosin EP Impurity N
|
四氫糠酰哌嗪
|
63074-07-7
|
Terazosin EP Impurity M
|
31350-27-3
|
Sugammadex sodium Org199129-1 Impurity
|
舒更葡糖鈉雜質(zhì)05
|
2412953-06-9
|
Rapamycin impurity 5
|
Rapamycin Impurity 6
|
500733-49-3
|
28-epi-Rapamycin
|
28-異帕雷帕霉素
|
253431-35-5
|
Pitavastatin Impurity 3
|
匹伐他汀鈣中間體
|
154057-58-6
|
Oxymetazoline EP Impurity B
|
賽洛唑啉
|
526-36-3
|
Norfloxacin EP Impurity H
|
諾氟沙星EP雜質(zhì)H
|
105440-01-5
|
Medetomidine Impurity 20
|
右美托咪啶 3
|
104245-83-2
|
Medetomidine Impurity 8
|
鹽酸左美托咪定
|
190000-46-5
|
Moxifloxacin impurity 26
|
丙烯酸鹽反應產(chǎn)物
|
161594-54-3
|
Avatrombopag impurity 43
|
6-(4-(乙氧基羰基)哌啶-1-基)-5-氯吡啶-3-羧酸
|
931395-73-2
|
Avatrombopag impurity 35
|
570403-04-2
|
570403-04-2
|
Avatrombopag impurity 34
|
2,3-DICHLOROPYRIDINE-5-CARBONYL CHLORIDE
|
54127-29-6
|
Avatrombopag impurity 26
|
5-溴-4-(4-氯噻吩-2-基)噻唑-2-胺
|
2161380-87-4
|
Avatrombopag impurity 8
|
2-溴-1-(4-氯-2-噻吩基)乙酮
|
677007-73-7
|
Formoterol Impurity 1
|
(R)-1-(4-芐氧基-3-硝基苯基)-2-溴乙醇
|
188690-82-6
|
Fusidic Acid EP Impurity O( Sodium Fusidate EP Impurity O)
|
夫西地酸雜質(zhì)O
|
13090-91-0
|
Fosaprepitant impurity 6
|
|
2514928-37-9
|
Dexrazoxane impurity 7
|
右雷佐生雜質(zhì)5
|
2084092-82-8
|
Cholesta-3,5-dien-7-one
|
cholesta-3,5-dien-7-one
|
567-72-6
|
VH032-NH-CO-CH2-NHBoc
|
VH032-BOC-氨基
|
2010986-19-1
|
Thalidomide-4-NH-PEG1-COO(t-Bu)
|
PROPANOIC ACID, 3-[2-[[2-(2,6-DIOXO-3-PIPERIDINYL)-2,3-DIHYDRO-1,3-DIOXO-1H-ISOINDOL-4-YL]AMINO]ETHO
|
2140807-19-6
|
Thalidomide-5-NH-CH2-COO(t-Bu)
|
THALIDOMIDE-5-NH-CH2-COO(T-BU)
|
2412056-28-9
|
Thalidomide-NH-(CH2)2-NH2 TFA
|
沙利度胺-NH-C2-NH2三氟醋酸鹽
|
1957235-67-4
|
VH032-NH-CO-CH2-NH2
|
(2S,4R)-1-((S)-2-(2-氨基乙酰胺基)-3,3-二甲基丁?;?-4-羥基-N-(4-(4-甲基噻唑-5-基)芐基)吡咯烷-2-甲酰胺
|
2010986-20-4
|
Avatrombopag impurity 5
|
4-(5-氯-2-噻吩)-1,3-噻唑-2-胺
|
123971-45-9
|
Rosuvastatin Impurity 9
|
Rosuvastatin D-5 Enatiomer Impurity
|
2375865-91-9
|
Latamoxef impurity 9
|
拉他莫西雜質(zhì)5
|
64076-52-4
|
Latamoxef impurity 13
|
|
65664-73-5
|
Levetiracetam EP Impurity C
|
2-羥基吡啶
|
142-08-5
|
Levetiracetam Impurity 8
|
4-氯丁酰氯
|
4635-59-0
|
Levocetirizine Impurity 1
|
左氯替西汀酰胺雜質(zhì)鹽酸鹽
|
909779-33-5
|
(S)-Cetirizine
|
(S)-西替利嗪
|
130018-76-7
|
Levocetirizine Impurity 11
|
Levocetirizine Impurity 4
|
70558-10-0
|
Levocetirizine Impurity 12
|
鹽酸左西替利嗪SM雜質(zhì)
|
109036-15-9
|
Moxifloxacin impurity 3
|
6-羥基莫西沙星
|
2445515-66-0
|
Moxifloxacin impurity 16
|
加替沙星雜質(zhì)15
|
2327019-81-6
|
Bromoacetaldehyde
|
溴乙醛
|
17157-48-1
|